scholarly article | Q13442814 |
P50 | author | José Pedro Gil | Q50907208 |
Pedro E. Ferreira | Q54802189 | ||
Anders Björkman | Q80329586 | ||
Andreas Mårtensson | Q91539704 | ||
Gabrielle Fröberg | Q91670807 | ||
P2093 | author name string | Abdullah Ali | |
P2860 | cites work | Evidence of Artemisinin-Resistant Malaria in Western Cambodia | Q22061854 |
Fitness and its role in evolutionary genetics | Q22122004 | ||
Amodiaquine for treating malaria | Q24248644 | ||
Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine | Q24807027 | ||
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum | Q27861931 | ||
PfMDR1: mechanisms of transport modulation by functional polymorphisms | Q28476753 | ||
Epidemiology of drug-resistant malaria | Q30830669 | ||
A molecular marker for chloroquine-resistant falciparum malaria | Q31921233 | ||
No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used | Q33498521 | ||
In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda | Q33676088 | ||
Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations | Q34198094 | ||
Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum | Q34767732 | ||
The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum | Q35095240 | ||
Population pharmacokinetics of artesunate and amodiaquine in African children | Q35575394 | ||
Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. | Q35647706 | ||
Contribution of the pfmdr1 gene to antimalarial drug-resistance | Q36117630 | ||
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria | Q37190605 | ||
Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis | Q37350167 | ||
Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20). | Q37422462 | ||
pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum | Q38331106 | ||
Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine | Q38980065 | ||
Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. | Q39307574 | ||
Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis | Q40572948 | ||
Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites | Q40616078 | ||
Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications | Q41292997 | ||
Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar | Q41827965 | ||
A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. | Q41912137 | ||
Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi | Q41915777 | ||
Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates. | Q41932849 | ||
A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum. | Q41946696 | ||
Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa | Q43945880 | ||
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania | Q43947607 | ||
Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. | Q46791619 | ||
The evolution of multiple drug resistance in malaria parasites | Q47837189 | ||
Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand | Q47858805 | ||
Validation of Pyrosequencing for accurate and high throughput estimation of allele frequencies in malaria parasites. | Q48037283 | ||
The cost of antibiotic resistance from a bacterial perspective | Q64129151 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Plasmodium falciparum | Q311383 |
parasite growth | Q122674855 | ||
P304 | page(s) | 887-892 | |
P577 | publication date | 2012-12-03 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Assessing the cost-benefit effect of a Plasmodium falciparum drug resistance mutation on parasite growth in vitro | |
P478 | volume | 57 |
Q34597342 | Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response |
Q40075854 | Differential gene expression in Anopheles stephensi following infection with drug-resistant Plasmodium yoelii |
Q58586501 | Emerging implications of policies on malaria treatment: genetic changes in the gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa |
Q35107675 | Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model |
Q36344786 | Fitness of artemisinin-resistant Plasmodium falciparum in vitro |
Q35874266 | Genome-wide transcriptome profiling reveals functional networks involving the Plasmodium falciparum drug resistance transporters PfCRT and PfMDR1 |
Q48024028 | Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda |
Q56440042 | Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in |
Q41547525 | Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya |
Q37538729 | Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy |
Q42246640 | Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy |
Q22061938 | Pumped up: reflections on PfATP6 as the target for artemisinins |
Q37425838 | Selection for chloroquine-sensitive Plasmodium falciparum by wild Anopheles arabiensis in Southern Zambia |
Q39206934 | pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies |
Search more.